BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8405930)

  • 1. Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis.
    Ichikawa Y; Yamagata H; Tochikubo K; Udaka S
    FEMS Microbiol Lett; 1993 Aug; 111(2-3):219-24. PubMed ID: 8405930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts.
    Daniell H; Lee SB; Panchal T; Wiebe PO
    J Mol Biol; 2001 Aug; 311(5):1001-9. PubMed ID: 11531335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression in Escherichia coli of two mutated genes encoding the cholera toxin B subunit.
    L'hoir C; Renard A; Martial JA
    Gene; 1990 Apr; 89(1):47-52. PubMed ID: 2197181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines.
    Lebens M; Johansson S; Osek J; Lindblad M; Holmgren J
    Biotechnology (N Y); 1993 Dec; 11(13):1574-8. PubMed ID: 7764248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of a mutant B subunit in toxigenic Vibrio cholerae diminishes production of active cholera toxin in vivo.
    Silva A; Fando R; Benitez JA
    Curr Microbiol; 1998 Oct; 37(4):231-5. PubMed ID: 9732528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of cholera toxin B subunit in Lactobacillus.
    Slos P; Dutot P; Reymund J; Kleinpeter P; Prozzi D; Kieny MP; Delcour J; Mercenier A; Hols P
    FEMS Microbiol Lett; 1998 Dec; 169(1):29-36. PubMed ID: 9851032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.
    Sanchez J; Holmgren J
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):481-5. PubMed ID: 2492108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface display of the cholera toxin B subunit on Staphylococcus xylosus and Staphylococcus carnosus.
    Liljeqvist S; Samuelson P; Hansson M; Nguyen TN; Binz H; Ståhl S
    Appl Environ Microbiol; 1997 Jul; 63(7):2481-8. PubMed ID: 9212399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli.
    Arêas AP; Oliveira ML; Ramos CR; Sbrogio-Almeida ME; Raw I; Ho PL
    Protein Expr Purif; 2002 Aug; 25(3):481-7. PubMed ID: 12182829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications of cholera toxin subunit B binding to human large intestinal epithelium. An immunohistochemical study.
    Kirkeby S; Lynge Pedersen AM
    Microb Pathog; 2018 Nov; 124():332-336. PubMed ID: 30145256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant cholera toxin B subunit in Escherichia coli: high-level secretion, purification, and characterization.
    Slos P; Speck D; Accart N; Kolbe HV; Schubnel D; Bouchon B; Bischoff R; Kieny MP
    Protein Expr Purif; 1994 Oct; 5(5):518-26. PubMed ID: 7827509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.
    Yu RK; Usuki S; Itokazu Y; Wu HC
    Glycobiology; 2016 Jan; 26(1):63-73. PubMed ID: 26405107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the immunogenic potential of plant-expressed cholera toxin B subunit.
    Jani D; Singh NK; Bhattacharya S; Meena LS; Singh Y; Upadhyay SN; Sharma AK; Tyagi AK
    Plant Cell Rep; 2004 Feb; 22(7):471-7. PubMed ID: 14517689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protein required for secretion of cholera toxin through the outer membrane of Vibrio cholerae.
    Sandkvist M; Morales V; Bagdasarian M
    Gene; 1993 Jan; 123(1):81-6. PubMed ID: 8423007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in epitopes of the B subunit of El Tor and classical biotype Vibrio cholerae O1 cholera toxin.
    Tamplin ML; Ahmed MK; Jalali R; Colwell RR
    J Gen Microbiol; 1989 May; 135(5):1195-200. PubMed ID: 2482860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of human interleukin-2 in biologically active form by Bacillus brevis directly into culture medium.
    Takimura Y; Kato M; Ohta T; Yamagata H; Udaka S
    Biosci Biotechnol Biochem; 1997 Nov; 61(11):1858-61. PubMed ID: 9404065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and arrangement of the cholera toxin genes in Vibrio cholerae O139.
    Lebens M; Holmgren J
    FEMS Microbiol Lett; 1994 Apr; 117(2):197-202. PubMed ID: 8181723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholera toxin B: one subunit with many pharmaceutical applications.
    Baldauf KJ; Royal JM; Hamorsky KT; Matoba N
    Toxins (Basel); 2015 Mar; 7(3):974-96. PubMed ID: 25802972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A secretion expression system using promoter and signal peptide of cholera toxin B subunit gene.
    Cao C; Shi C; Li P; Ma Q
    Chin J Biotechnol; 1995; 11(2):79-86. PubMed ID: 8562852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Bacillus brevis for efficient synthesis and secretion of human epidermal growth factor.
    Yamagata H; Nakahama K; Suzuki Y; Kakinuma A; Tsukagoshi N; Udaka S
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3589-93. PubMed ID: 2786200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.